KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Change in Acquisitions & Divestments: 2011-2025

Historic Change in Acquisitions & Divestments for Pacira BioSciences (PCRX) over the last 14 years, with Sep 2025 value amounting to $86.2 million.

  • Pacira BioSciences' Change in Acquisitions & Divestments rose 62.23% to $86.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $273.6 million, marking a year-over-year increase of 62.16%. This contributed to the annual value of $179.6 million for FY2024, which is 24.25% down from last year.
  • According to the latest figures from Q3 2025, Pacira BioSciences' Change in Acquisitions & Divestments is $86.2 million, which was up 21.19% from $71.2 million recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Change in Acquisitions & Divestments ranged from a high of $598.1 million in Q4 2021 and a low of $33.5 million during Q2 2023.
  • Over the past 3 years, Pacira BioSciences' median Change in Acquisitions & Divestments value was $46.9 million (recorded in 2024), while the average stood at $58.5 million.
  • As far as peak fluctuations go, Pacira BioSciences' Change in Acquisitions & Divestments soared by 290.67% in 2021, and later crashed by 85.80% in 2022.
  • Over the past 5 years, Pacira BioSciences' Change in Acquisitions & Divestments (Quarterly) stood at $598.1 million in 2021, then crashed by 85.80% to $84.9 million in 2022, then tumbled by 57.50% to $36.1 million in 2023, then surged by 30.05% to $46.9 million in 2024, then soared by 62.23% to $86.2 million in 2025.
  • Its Change in Acquisitions & Divestments was $86.2 million in Q3 2025, compared to $71.2 million in Q2 2025 and $69.2 million in Q1 2025.